Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
about
The molecular biology of pelvi-ureteric junction obstruction.Novel method to collect medication adverse events in juvenile arthritis: results from the childhood arthritis and rheumatology research alliance enhanced drug safety surveillance project.A reappraisal of the 6-O-desmethylnaproxen-sulfating activity of the human cytosolic sulfotransferases.
P2860
Safety of celecoxib and nonselective nonsteroidal anti-inflammatory drugs in juvenile idiopathic arthritis: results of the Phase 4 registry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@ast
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@en
type
label
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@ast
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@en
prefLabel
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@ast
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@en
P2093
P2860
P356
P1476
Safety of celecoxib and nonsel ...... sults of the Phase 4 registry.
@en
P2093
Beth S Gottlieb
Daniel J Lovell
Donald P Goldsmith
Edward H Giannini
Elizabeth C Chalom
Hermine I Brunner
James P Young
Jennifer E Weiss
Kabita Nanda
Lawrence K Jung
P2860
P2888
P356
10.1186/1546-0096-12-29
P577
2014-07-16T00:00:00Z
P5875
P6179
1022152532